Barriers and Stimulus in Shared Decision Making Among Aesthetic Dermatologists in China: Findings from a Cross-Sectional Study
Jing Fan,Shiyuan Li,Yan Qiang,Zhen Duan,Albert Wu,Ruiping Wang
DOI: https://doi.org/10.2147/ccid.s457802
2024-05-21
Clinical Cosmetic and Investigational Dermatology
Abstract:Jing Fan, 1, 2, &ast Shiyuan Li, 3, &ast Yan Qiang, 1, &ast Zhen Duan, 3 Albert Wu, 2 Ruiping Wang 1– 3 1 Clinical Research Center, Shanghai Skin Diseases Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Bloomberg School of Public Health, University of Johns Hopkins, Baltimore, MD, USA; 3 School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ruiping Wang, Email Introduction: Shared decision making (SDM) is a collaborative process involving both healthcare providers and patients in making medical decisions, which gains increasing prominence in healthcare practice. But evidence on the level of SDM in medical practice and barriers as well as stimulus during the SDM implementation among aesthetic dermatologists is limited in China. Methods: From July to August 2023, 1938 dermatologists were recruited online in China. Data were collected through an electronic questionnaire covering: (1) demographic features; (2) SDM questionnaire physician version (SDM-Q-Doc); and (3) stimulus and barriers in SDM implementation. Logistic regression was applied to explore factors associated with SDM practice, barriers, and stimulus of SDM implementation, respectively. Results: The 1938 dermatologists included 1329 females (68.6%), with an average age of 35 years. The total SDM score ranged from 0 to 45, with a median value of 40 (IQR: 35– 44), and the median stimulus score and barriers scores were 28 (IQR: 24– 32) and 19 (IQR: 13– 26), respectively. The prevalence of good SDM was 27.2%, logistic regression indicated that female dermatologists (odds ratio, OR=1.21, 95% confidence interval, CI: 0.96– 1.51), and dermatologists with more years of aesthetic practice had a higher proportion of good SDM practice (OR was 1.44 for 5– 9 years, 1.58 for 10– 15 years and 1.77 for over 15 years). Moreover, female dermatologists and dermatologists with higher education level and serviced in private settings had lower barrier scores; female dermatologists and dermatologists with more years of aesthetic practice had higher stimulus scores. Conclusion: Chinese aesthetic dermatologists appear to implement SDM at an active level, with more stimulus and less barriers in SDM implementation. The integration of SDM into clinical practice among dermatologists is beneficial both for patients and dermatologists. Moreover, SDM practice should be strongly promoted and enhanced during medical aesthetics, especially among male dermatologists, dermatologists with less working experience, and those who work at public institutions. Keywords: shared decision making, dermatologist, good practice, barriers, stimulus Shared decision making (SDM) has gained increasing prominence in healthcare practice with the rising recognition of patient-centered care in past decades. 1–3 It involves a collaborative process where healthcare providers and patients make a medical decision together. 4 The clinician provides information on treatment options, benefits, and risks, while the patient provides information about their preference and treatment goals. Besides achieving an agreement aligned with patient's value, SDM is also equally critical to offer comfort and support to the family or surrogate as an essential aspect of shared decision making. 5 Constantly, patients highlight the communication with the healthcare providers as being one of their most important concerns, with the majority of the patient's family members or surrogates expressing a desire for both themselves and physicians to be actively involved in the medical decision-making process. 6,7 SDM implementation could increase patients' quality of life, and patients who experience higher levels of SDM participation have better reported health outcomes and decreased healthcare utilization. 7 Medical aesthetics has been experiencing substantial growth in China since the 1980s due to the cultural attitudes toward beauty, societal pressures, and the growing demand for cosmetic procedures, with a Compound Annual Growth Rate (CAGR) ranging from 17% to 23% in the past 5 years. 8 The overall medical aesthetic market is expected to reach a valuation of $50 billion by 2026. It is worth noting that medical aesthetic industry in China comprises more than 10,000 facilities, including hospitals, outpatient centers, and clinics, all regulated by the China Healthcare Commission. The aim of medical aesthetic intervention is to enhance an individual's overall appearance and -Abstract Truncated-
dermatology